Daily Archives: January 23, 2009
Indianapolis – It could be a major step forward for stem cell research and patients paralyzed with spinal cord injuries. An American biotech company is now poised to launch the world’s first study of a treatment based on human embryonic stem cells.
Sam Schmidt is beaming at the news. Advancing research for the paralyzed is what he’s lobbied for over the past eight years.
“It’s not like winning the Indy 500 but it’s pretty darn close,” said Schmidt.
The FDA has approved the first use of embryonic stem cells to treat humans. It’s never been done before in the United States, but the FDA has now cleared the way for eight to ten patients with spinal cord injuries to be treated with embryonic stem cells sometime this summer.
Christopher Reeve didn’t live to see the day he worked so hard for, a treatment with the potential to repair spinal cords that would allow paraplegics to walk again.
FDA approves Geron Corp. clinical trial for spinal cord injury treatment
Irvine, Calif., Jan. 23, 2009 A therapy developed at UC Irvine that made paralyzed rats walk again will become the world’s first embryonic stem cell treatment tested in humans.